Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

22.50 -1.72 (-7.12%)
Streaming Delayed Price Updated: 11:33 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,215,175
Open 23.41
Bid (Size) 22.47 (6)
Ask (Size) 22.52 (5)
Prev. Close 24.22
Today's Range 21.53 - 23.66
52wk Range 23.27 - 81.86
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Smartest Biotech Stocks to Buy With $50
Via The Motley Fool
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
Via The Motley Fool

Performance

YTD
-45.3%
-45.3%
1 Month
-19.9%
-19.9%
3 Month
-45.3%
-45.3%
6 Month
-64.9%
-64.9%
1 Year
-71.3%
-71.3%

More News

Read More
Which Healthcare Stock Is the Best Buy Right Now?
Via MarketBeat
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study
Via Investor's Business Daily
Is Viking Therapeutics a Buy Right Now?
Via The Motley Fool
Motley Fool 2025 March Market Cap Showdown Championship
Via The Motley Fool
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
Via The Motley Fool
MarketBeat Week in Review – 03/17 - 03/21
Via MarketBeat
Topics Economy Government World Trade
Exposures Economy Interest Rates Political
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street
Via The Motley Fool
Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?
Via The Motley Fool
Is Novo Nordisk a No-Brainer Buy After It Dropped 40%?
Via The Motley Fool
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
Via MarketBeat
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.
Via Investor's Business Daily
Is Eli Lilly Stock a Buy?
Via The Motley Fool
The State of Weight Loss Drugs
Via The Motley Fool
BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Via Benzinga
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
Via Investor's Business Daily
MarketBeat Week in Review – 02/24 - 02/28
Via MarketBeat
Topics Economy World Trade
Exposures Interest Rates Tariff
1 Biotech Stock to Buy in 2025, and 1 to Avoid
Via The Motley Fool
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
Via The Motley Fool
Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
Via MarketBeat
Exposures Product Safety
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 22.50
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 04/04/25 11:33 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.24B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.